Related Experiment Videos
Adjuvant systemic therapy in young women
Daniel R Carrizosa1, Lisa A Carey
1Division of Hematology/Oncology, University of North Carolina at Chapel Hill, 27599-7305, USA.
Breast Disease
|July 11, 2006
Summary
This study addresses unique breast cancer treatment challenges for premenopausal women under 50. It explores cytotoxic, biologic, endocrine, and chemoendocrine therapies, plus survivorship concerns.
Area of Science:
- Oncology
- Women's Health
- Cancer Survivorship
Background:
- Breast cancer diagnosis is common in women under 50, representing about one-third of new cases.
- Premenopausal women encounter standard adjuvant treatment challenges alongside age-specific issues related to hormonal status and longer life expectancy.
Purpose of the Study:
- To examine treatment issues for premenopausal women with breast cancer.
- To explore controversies in endocrine and chemoendocrine therapy for this demographic.
- To investigate survivorship challenges unique to young breast cancer survivors.
Main Methods:
- Review of current literature on breast cancer treatment in premenopausal women.
- Analysis of adjuvant, cytotoxic, biologic, endocrine, and chemoendocrine therapeutic approaches.
- Exploration of survivorship issues specific to younger patients.
Main Results:
- Young women face distinct challenges in breast cancer treatment due to their hormonal status and longer life expectancy.
- Optimal endocrine and chemoendocrine therapy strategies remain a subject of ongoing debate.
- Survivorship issues require tailored approaches for young breast cancer patients.
Conclusions:
- Further research is needed to optimize breast cancer treatment and survivorship care for premenopausal women.
- Addressing the unique needs of young women with breast cancer is crucial for improving long-term outcomes.
- Tailored therapeutic strategies and survivorship support are essential for this population.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...